A Functional Polymorphism in the CHRNA3 Gene and Risk of Chronic Obstructive Pulmonary Disease in a Korean Population

A genome-wide association study has identified the 15q25 region as being associated with the risk of chronic obstructive pulmonary disease (COPD) in Caucasians. This study intended as a confirmatory assessment of this association in a Korean population. The rs6495309C > T polymorphism in the promoter of nicotinic acetylcholine receptor alpha subunit 3 (CHRNA3) gene was investigated in a case-control study that consisted of 406 patients with COPD and 394 healthy control subjects. The rs6495309 CT or TT genotype was associated with a significantly decreased risk of COPD when compared to the rs6495309 CC genotype (adjusted odds ratio = 0.69, 95% confidence interval = 0.50-0.95, P = 0.023). The effect of the rs6495309C > T on the risk of COPD was more evident in moderate to very severe COPD than in mild COPD under a dominant model for the variant T allele (P = 0.024 for homogeneity). The CHRNA3 rs6495309C > T polymorphism on chromosome 15q25 is associated with the risk of COPD in a Korean population.

[1]  J. Park,et al.  A Functional Polymorphism on Chromosome 15q25 Associated with Survival of Early Stage Non–Small-Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  L. Edwards,et al.  Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[3]  J. Hirschhorn.  Genomewide association studies--illuminating biologic pathways. , 2009, The New England journal of medicine.

[4]  T. Jung,et al.  SERPINE2 Polymorphisms and Chronic Obstructive Pulmonary Disease , 2009, Journal of Korean medical science.

[5]  Ming D. Li,et al.  Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[7]  Wen Tan,et al.  Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. , 2009, Cancer research.

[8]  John P. A. Ioannidis,et al.  Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.

[9]  K. Frazer,et al.  Human genetic variation and its contribution to complex traits , 2009, Nature Reviews Genetics.

[10]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[11]  Tatiana Foroud,et al.  Variants in nicotinic receptors and risk for nicotine dependence. , 2008, The American journal of psychiatry.

[12]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[13]  S. Heath,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[14]  K. Taylor,et al.  Genome-Wide Association , 2007, Diabetes.

[15]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[16]  L. Donnelly,et al.  The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? , 2007, Pharmacology & therapeutics.

[17]  J. Vestbo,et al.  Developing COPD: a 25 year follow up study of the general population , 2006, Thorax.

[18]  B. Canning,et al.  Reflex regulation of airway smooth muscle tone. , 2006, Journal of applied physiology.

[19]  J. Luketich,et al.  Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts , 2004, Respiratory research.

[20]  P. Barnes,et al.  Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review , 2004, Respiratory research.

[21]  D. Rogers.  Motor control of airway goblet cells and glands. , 2001, Respiration physiology.

[22]  M. Caulfield,et al.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.

[23]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[24]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[25]  K. Spiropoulos,et al.  Genetics of chronic obstructive pulmonary disease, beyond a1-antitrypsin deficiency. , 2006, Current medicinal chemistry.

[26]  C. Kirkpatrick,et al.  Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. , 1998, Pharmacology & therapeutics.